Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SOLV | ISRG |
|---|---|---|
| Price | $87.12 | $402.68 |
| Change today | ▼ 1.17% | ▼ 0.97% |
| Market cap | $14.83B | $142.26B |
| Return, 3 months | +11.2% | +0.1% |
| Return, year to date | +9.9% | -28.9% |
| Return, 1 year | +19.3% | -8.1% |
| P/E (TTM) | 10.7 | 46.2 |
| P/B | 3.1 | 7.8 |
| P/E percentile vs own 5y | 46th | 3rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +2.2% | +18.5% |
| Net profit growth (YoY) | +3.3% | +23.9% |
| Gross margin | 54.7% | 66.7% |
| Operating margin | 6.3% | 31.3% |
| Net margin | 17.3% | 28.4% |
| Return on equity | 34.0% | 17.4% |
| Analyst target vs. price | +12.7% | +21.7% |
| Analyst buy share | 70% | 86% |
| RSI (14) | 47 | 62 |
| 30-day volatility | 17.5% | 31.3% |
| Max drawdown, 1 year | -27.5% | -44.0% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
